February 22, 2016
The U.S. Food and Drug Administration (FDA) announced the recall of more than 275,000 bottles of candesartan cilexetil tablets, 16 mg.
The Class III recall was launched after the tablets failed the impurities/degredation specifications at nine months, according to the report.
The drugs in question were manufactured by Indian drug manufacturer Mylan Laboratories for Sandoz of Princeton, New Jersey.
The following presentations are being recalled:
Pills per bottle
Indian drug manufacturing has had its share of woes. Click here to read more.
Click here to read the FDA’s report about this recall.
1. U.S. Food and Drug Administration. Enforcement Report – Week of February 17, 2016. www.fda.gov. Accessed February 22, 2016.